📣 VC round data is live. Check it out!

Akdital Valuation Multiples

Discover revenue and EBITDA valuation multiples for Akdital and similar public comparables like Astrana Health, Draegerwerk, MLP Sağlık, Siloam Hospitals and more.

Akdital Overview

About Akdital

Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.


Founded

2016

HQ

Morocco

Employees

7.1K

Website

akdital.ma

Financials (LTM)

Revenue: $564M
EBITDA: $156M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Akdital Financials

Akdital reported last 12-month revenue of $564M and EBITDA of $156M.

In the same LTM period, Akdital generated $156M in EBITDA and $54M in net income.

Revenue (LTM)


Akdital P&L

In the most recent fiscal year, Akdital reported revenue of $494M and EBITDA of $146M.

Akdital is profitable as of last fiscal year, with gross margin of 49%, EBITDA margin of 30%, and net margin of 10%.

See analyst estimates for Akdital
LTMLast FY202320242025202620272028
Revenue$564M$494M$213M$331M$494M
Gross Profit—$241M$108M$168M$241M
Gross Margin—49%50%51%49%
EBITDA$156M$146M$62M$98M$146M
EBITDA Margin28%30%29%30%30%
EBIT Margin18%18%17%18%18%
Net Profit$54M$50M$20M$35M$50M
Net Margin10%10%9%11%10%

Financial data powered by Morningstar, Inc.

Akdital Stock Performance

Akdital has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Akdital's stock price is $131.51.

Akdital share price increased by 0.2% in the last 30 days, and decreased by 14.8% in the last year.

Akdital has an EPS (earnings per share) of $3.51.

See more trading valuation data for Akdital
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B3.2%0.2%6.9%-14.8%$3.51

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Akdital Valuation Multiples

Akdital trades at 3.8x EV/Revenue multiple, and 13.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Akdital

EV / Revenue (LTM)


Akdital Financial Valuation Multiples

As of May 24, 2026, Akdital has market cap of $2B and EV of $2B.

Akdital has a P/E ratio of 34.6x.

LTMLast FY202320242025202620272028
EV/Revenue3.8x4.4x10.1x6.5x4.4x
EV/EBITDA13.8x14.8x34.8x22.0x14.8x
EV/EBIT21.3x23.8x58.7x37.1x23.8x
EV/Gross Profit—8.9x20.0x12.8x8.9x
P/E34.6x37.5x95.2x52.9x37.5x
EV/FCF(12.6x)(12.2x)(24.7x)(7.9x)(9.3x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Akdital Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Akdital Margins & Growth Rates

Akdital grew revenue by 40% and EBITDA by 30% in the last fiscal year.

In the most recent fiscal year, Akdital reported gross margin of 49%, EBITDA margin of 30%, and net margin of 10%.

See estimated margins and future growth rates for Akdital

Akdital Margins

Last FY202420252026202720282029
Gross Margin49%51%49%—
EBITDA Margin30%30%30%27%
EBIT Margin18%18%18%17%
Net Margin10%11%10%9%
FCF Margin(36%)(82%)(47%)(23%)

Akdital Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth40%55%49%40%
Gross Profit Growth—56%44%—
EBITDA Growth30%58%49%30%
EBIT Growth30%58%56%30%
Net Profit Growth25%80%41%25%
FCF Growth(9%)212%(15%)(30%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Akdital Operational KPIs

Akdital's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Akdital's Rule of 40 is 67% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Akdital's Rule of X is 127% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Akdital
LTMLast FY202320242025202620272028
Rule of 4067%67%———
Bessemer Rule of X126%127%———
Revenue per Employee—$0.1M———
Opex per Employee—$0.0M———
Opex to Revenue—31%33%33%31%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Akdital Competitors

Akdital competitors include Astrana Health, Draegerwerk, MLP Sağlık, Siloam Hospitals, Surgery Partners, Pediatrix, OdontoPrev, Select Medical, Huaxia Eye Hospital Group and Acadia Healthcare.

Most Akdital public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Astrana Health0.8x0.7x12.0x10.7x
Draegerwerk0.4x0.4x4.0x3.9x
MLP Sağlık1.7x1.6x5.4x5.6x
Siloam Hospitals2.5x2.4x10.1x9.8x
Surgery Partners1.7x1.7x9.9x10.6x
Pediatrix1.1x1.1x7.4x7.3x
OdontoPrev—3.3x—10.4x
Select Medical0.9x0.9x9.4x9.9x

This data is available for Pro users. Sign up to see all Akdital competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Akdital

When was Akdital founded?Akdital was founded in 2016.
Where is Akdital headquartered?Akdital is headquartered in Morocco.
How many employees does Akdital have?As of today, Akdital has over 7K employees.
Who is the CEO of Akdital?Akdital's CEO is Rochdi Talib.
Is Akdital publicly listed?Yes, Akdital is a public company listed on Casablanca Stock Exchange.
What is the stock symbol of Akdital?Akdital trades under AKT ticker.
When did Akdital go public?Akdital went public in 2022.
Who are competitors of Akdital?Akdital main competitors include Astrana Health, Draegerwerk, MLP Sağlık, Siloam Hospitals, Surgery Partners, Pediatrix, OdontoPrev, Select Medical, Huaxia Eye Hospital Group, Acadia Healthcare.
What is the current market cap of Akdital?Akdital's current market cap is $2B.
What is the current revenue of Akdital?Akdital's last 12 months revenue is $564M.
What is the current revenue growth of Akdital?Akdital revenue growth (NTM/LTM) is 39%.
What is the current EV/Revenue multiple of Akdital?Current revenue multiple of Akdital is 3.8x.
Is Akdital profitable?Yes, Akdital is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Akdital?Akdital's last 12 months EBITDA is $156M.
What is Akdital's EBITDA margin?Akdital's last 12 months EBITDA margin is 28%.
What is the current EV/EBITDA multiple of Akdital?Current EBITDA multiple of Akdital is 13.8x.
What is the current FCF of Akdital?Akdital's last 12 months FCF is ($170M).
What is Akdital's FCF margin?Akdital's last 12 months FCF margin is (30%).
What is the current EV/FCF multiple of Akdital?Current FCF multiple of Akdital is (12.6x).
How many companies Akdital has acquired to date?Akdital hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Akdital has invested to date?Akdital hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Akdital

Lists including Akdital

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial